Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presurgical pharmacodynamic study of LEE011 plus letrozole versus letrozole alone in primary breast cancer
2013-002588-24Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing LEE011 plus letrozole with Letrozole alone (2 arms). Primary endpoint: Cell cycle response rate. Started Aug 2013; status: completed.
02
Drugs
ribociclibletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-002588-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002588-24.